JPS6120525B2 - - Google Patents

Info

Publication number
JPS6120525B2
JPS6120525B2 JP51147899A JP14789976A JPS6120525B2 JP S6120525 B2 JPS6120525 B2 JP S6120525B2 JP 51147899 A JP51147899 A JP 51147899A JP 14789976 A JP14789976 A JP 14789976A JP S6120525 B2 JPS6120525 B2 JP S6120525B2
Authority
JP
Japan
Prior art keywords
virus
hpa23
compound
sodate
antimonio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP51147899A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5294431A (en
Inventor
Kuroodo Sheruman Jan
Jasumin Kuroodo
Maasu Joruju
Reinoo Maruseru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AJANSU NASHONARU DO BARORIZASHION DO RA RUSHERUSHE
Original Assignee
AJANSU NASHONARU DO BARORIZASHION DO RA RUSHERUSHE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7605084A external-priority patent/FR2334366A2/fr
Application filed by AJANSU NASHONARU DO BARORIZASHION DO RA RUSHERUSHE filed Critical AJANSU NASHONARU DO BARORIZASHION DO RA RUSHERUSHE
Publication of JPS5294431A publication Critical patent/JPS5294431A/ja
Publication of JPS6120525B2 publication Critical patent/JPS6120525B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00—Compounds of tungsten
    • C01G41/006—Compounds containing tungsten, with or without oxygen or hydrogen, and containing two or more other elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00—Crystal-structural characteristics
    • C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • C01P2002/82—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/60—Optical properties, e.g. expressed in CIELAB-values

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP14789976A 1975-12-10 1976-12-10 Antiivirus agent treatment for virus inffction and prevention method Granted JPS5294431A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63941375A 1975-12-10 1975-12-10
FR7605084A FR2334366A2 (fr) 1975-12-10 1976-02-24 Application a titre d'agents antiviraux de composes d'heteropolyanions contenant du tungstene combine a de l'antimoine

Publications (2)

Publication Number Publication Date
JPS5294431A JPS5294431A (en) 1977-08-09
JPS6120525B2 true JPS6120525B2 (enExample) 1986-05-22

Family

ID=26219311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14789976A Granted JPS5294431A (en) 1975-12-10 1976-12-10 Antiivirus agent treatment for virus inffction and prevention method

Country Status (2)

Country Link
JP (1) JPS5294431A (enExample)
GB (1) GB1573002A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0629191B2 (ja) * 1984-09-04 1994-04-20 株式会社ポリトロニクス 抗腫瘍剤、抗ウィルス剤
IL77188A (en) * 1984-12-03 1989-03-31 Pasteur Institut Pharmaceutical compositions containing hpa23 for the treatment of acquired immune deficiency syndrome and analogous syndromes
JP2707252B2 (ja) * 1987-08-03 1998-01-28 利博 山瀬 抗ウィルス剤

Also Published As

Publication number Publication date
JPS5294431A (en) 1977-08-09
GB1573002A (en) 1980-08-13

Similar Documents

Publication Publication Date Title
US5153181A (en) Pharmaceutical compositions comprising organic polymers containing inorganic anionic groups and method of prophylaxis and treatment of retrovirus infections in mammals using said compositions
Hilleman Prospects for the use of double-stranded ribonucleic acid (poly I: C) inducers in man
US4547369A (en) Antiviral agent
US6316495B1 (en) Method for inhibition of retroviral replication
CN111821310A (zh) 一种瑞德西韦制剂及其适应症
KR940010441B1 (ko) B형감염의 항비루스제
JPS6120525B2 (enExample)
Diana et al. Chemotherapy of virus diseases
US4039656A (en) Production of attenuated viruses
RU2088232C1 (ru) Ингибитор репродукции вируса марбург
EP1338281B1 (en) Method for producing an immunotropic antiviral preparation
EP0344643B1 (en) Antiviral pharmaceutical composition
JPH02500524A (ja) １‐（２’‐デオキシ‐２’‐フルオロ‐β―Ｄ―アラビノ―フラノシル）‐５‐エチルウラシルを使用する肝炎ウイルス感染症の治療用組成物及び方法
JPH04501857A (ja) 肝炎の治療方法
Rowson et al. STUDIES ON THE MECHANISM OF ACTION OF RILEY VIRUS: II. Action of Substances Affecting the Reticuloendothelial System on the Level of Viraemia
EP0369776B1 (en) Use of a composition containing organic germanium for the manufacture of a medicament for treating AIDS
JPH0551565B2 (enExample)
JPS6140206B2 (enExample)
Cronin Antiviral agents
Stringfellow Chemotherapy of viral infections
US3773928A (en) Treatment of virus-induced diseases with orgotein
EP0351625B1 (en) Anti-hiv activity of bv-3608
JPS5946496B2 (ja) 抗ヘルペス・ウイルス剤
JPH1087503A (ja) 神経系腫瘍細胞のアポトーシス剤
Cronin Antiviral agents